A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Celltrion
Related studies linked through entity extraction aliases.
Infliximab in the Treatment of Patients With Severe COVID-19 Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
- Status
- TERMINATED
- Phase
- PHASE1
To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17
- Status
- COMPLETED
- Phase
- PHASE1
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants
- Status
- COMPLETED
- Phase
- PHASE1